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INTRODUCTION
Airway hyperresponsiveness (AHR) is a characteristic fea-
ture of asthma. It reflects a tendency for bronchi to over-nar-
row in response to various provocative stimuli (1). Asthma
is usually diagnosed in patients with both AHR and respi-
ratory symptoms, such as, dyspnea, cough, wheeze, or chest
tightness. Although AHR is a cardinal feature in asthma, a
significant proportion of individuals without past or present
history of asthma and other respiratory diseases show an
increased physiologic airway response to agents such as his-
tamine or methacholine or to stimuli such as exercise with no
respiratory symptoms (1). This is usually referred to as asymp-
tomatic AHR.
The prevalence of AHR in the general population varies
from 4 to 35% (1, 2). In our previous study, the prevalence
of AHR in adults was determined to be 6.6% (3). However,
the prevalence of asymptomatic AHR in the general popu-
lation has not been well established and varies greatly from
one survey to another. The majority of surveys have report-
ed a prevalence of under 15% in adults (1, 2). In children,
reported prevalences vary in much the same way, i.e., from
8 to 33% (2).
Asymptomatic AHR is believed to be associated with air-
way inflammation and remodeling (4, 5). However, few stud-
ies have examined bronchial inflammation and remodeling
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Atopy May Be an Important Determinant of Subepithelial Fibrosis in
Subjects with Asymptomatic Airway Hyperresponsiveness
The bronchial pathology of asymptomatic airway hyperreponsiveness (AHR) sub-
jects is not well understood, and the role of atopy in the development of airway remod-
eling is unclear. The aim of this study was to evaluate whether atopy is associated
with airway remodeling in asymptomatic AHR subjects. Five groups, i.e., atopic or
non-atopic subjects with asymptomatic AHR, atopic or non-atopic healthy controls,
and subjects with mild atopic asthma, were evaluated by bronchoscopic biopsy.
By electron microscopy, mean reticular basement membrane (RBM) thicknesses
were 4.3± ±1.7 m,  3.4± ±1.8 m,  2.5± ±1.5 m,  2.6± ±1.1  m, and 2.3± ±1.2 m  in
the mild atopic asthma, atopic and non-atopic asymptomatic AHR, atopic and non-
atopic control groups, respectively (p=0.002). RBM thicknesses were significantly
higher in the mild atopic asthma group and in the atopic asymptomatic AHR group
than in the other three groups (p=0.048). No significant difference in RBM thickness
was observed between the atopic asymptomatic AHR group and the mild atopic
asthma group (p>0.05), nor between non-atopic asymptomatic AHR group and
the two control groups (p>0.05). By light microscopy, subepithelial layer thickness-
es between the groups showed the same results. These findings suggest that RBM
thickening occurs in subjects with atopic asymptomatic AHR, and that atopy plays
an important role in airway remodeling.
Key Words : Asymptomatic Airway Hyperresponsiveness; Atopy; Airway Remodeling; Reticular Basement
Membrane; Subepithelial Layer Thickness
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in asymptomatic AHR subjects. Laprise et al. reported that
findings of airway inflammation in an asymptomatic AHR
group showed epithelial desquamation and focal irregular
subepithelial fibrosis, which were similar to those of asthma
by bronchial biopsy (4). In addition, median percentages of
eosinophils in induced sputum were found to be similar in
asthmatic and asymptomatic AHR (5). 
Atopy has also been associated with airway remodeling
and reticular basement membrane (RBM) thickening (6, 7),
the latter of which was found to be significantly thicker in
atopic asthma than in non-atopic asthma (8). 
Asymptomatic AHR and atopy seem to be independent
risk factors for the development of asthma (1, 4, 6, 8-11). In
one study, atopic subjects with asymptomatic AHR showed
a greater frequency of asthma symptom development than
normoresponsive subjects over a 3-yr period (9). Moreover,
asymptomatic children with AHR were found to be more
likely to develop asthma and atopy later in life than asymp-
tomatic children without AHR (10).
The purpose of this study was to evaluate whether RBM
thickening begins in asymptomatic AHR subjects and whether
atopy can influence airway remodeling in asymptomatic AHR
subjects. 
MATERIALS AND METHODS
Subjects
Twenty eight non-smoking volunteers were recruited. A
questionnaire including asthma, allergy, and smoking histo-
ry was administered. Methacholine bronchial provocation
test and skin prick test were done. With given informed con-
sent, a bronchoscopic examination was done. These 28 study
subjects were then divided into five groups according to res-
piratory symptoms, and the presences of airway hyperrespon-
siveness and atopy, i.e., atopic or nonatopic subjects with
asymptomatic AHR, mild atopic asthmatics, atopic or nona-
topic controls. Subjects’ ages ranged from 22 to 32 yr. 
Twelve subjects with asymptomatic AHR had a provoca-
tive concentration of methacholine causing a 20% fall in
forced expiratory volume in one second (PC20) of ≤16 mg/
mL. All denied any past or present symptoms suggestive of
asthma (including intermittent dyspnea, wheezing, or a recur-
rent cough) or rhinitis. Seven of these were atopic and 5 were
non-atopic. None of these 12 had contracted a respiratory
infection during the month preceding this study.
A mild atopic asthma group of two subjects with current
mild intermittent symptoms used only intermittent bron-
chodilator inhalation. Both were atopic without rhinitis and
were stable at the time of the study, and neither had experi-
enced a respiratory infection nor asthma exacerbation during
the month preceding this study. Asthma was defined accord-
ing to the criteria proposed by the American Thoracic Soci-
ety (ATS) (12).
Two control groups were also studied; an atopic control
group of 7 subjects, and a non-atopic control group of 7 sub-
jects. Selection criteria for these control groups were PC20
>16 mg/mL, no current or past symptoms suggesting asth-
ma, rhinitis or other respiratory disease, no medication and
no respiratory infection during the prior month. 
This study was approved by the hospital medical ethics
committee of Seoul National University Hospital, and all
participants gave informed consent. 
Procedures 
All five study groups were evaluated at baseline. Charac-
teristics of subjects and symptoms were documented accord-
ing to responses to a detailed structured questionnaire.
Skin prick tests were performed using a battery of 16 com-
mon inhalant allergens, which included Dermatophagoides
farinae and D. pteronyssinus, the two-spotted mite, Tyropha-
gus, cat, cockroach, ragweed, mugwort, mixed trees, mixed
grasses, and mixed fungi (Allergopharma, Reinbek, Germany),
as previously described (13). Normal saline and histamine
dihydrochloride (Allergopharma) were used as negative and
positive controls, respectively. Atopy was defined as the pres-
ence of at least one positive response to skin prick test (wheal
diameter of allergen/wheal diameter of histamine ≥1 and
mean wheal size ≥3 mm). Inhalant allergens were divided
into five categories: house dust mite, tree pollens, grass pol-
lens, animal danders, and molds. Atopic index was defined as
the number of inhalant allergen categories (0-5) to which a
patient showed at least one positive response on skin prick
test (4). 
Methacholine bronchial provocation tests were performed
as previously described (14). AHR was defined as the provoca-
tive concentration of methacholine causing a 20% decline
in FEV1 (PC20) of ≤16 mg/mL. PC20 was obtained by inter-
polating dose-response curves to a 20% fall in FEV1. 
Bronchoscopy
Study subjects underwent bronchoscopy at a day care unit
using a standard set up, as described by the American Tho-
racic Society (15). They were admitted in the morning after
an overnight fast. After making baseline observations, all
subjects received 2.5 mg of nebulized salbutamol and 600
g of atropine intramuscularly as premedication. A lidocaine
spray was applied to the oropharynx, and 4% lidocaine was
installed via a bronchoscope to the vocal cords. Additional
2% lidocaine was administered to the tracheobronchial tree.
Oxygen at 2 L/min was delivered during the procedure and
subjects were monitored by pulse oximetry. Bronchial biop-
sies were obtained from the carinae of second-order bronchi of
the right, middle, and lower lobes.392 S.-W. Sohn, Y.-S. Chang, H.-S. Lee, et al.
Histology
For histologic analysis, all bronchoscopic biopsies were
fixed in phosphate-buffered formalin, dehydrated in alco-
hol, and embedded in paraffin. Four-micrometer sections
were cut from each tissue block, deparaffinized, dehydrated,
and stained with hematoxylin and eosin (H&E). Subepithe-
lial fibrosis was evidenced by the regular deposition of colla-
gen fibers under the basement membrane. The measurements
of subepithelial layer thicknesses were made from the base
of the bronchial epithelium to its outer limit perpendicular-
ly to the outermost edge of the basement membrane. The
measurement, therefore, included the true basement mem-
brane as well as reticular components. Maximum and mini-
mum thicknesses were determined at each 3 different sites
per biopsy sample. 
Electron microscopy
For electron microscopy (EM), biopsy samples were fixed
in 10% neutral formalin then in 3.0% glutaraldehyde, wash-
ed in cold 0.1 M phosphate buffer (pH 7.4), postfixed in 1%
osmium tetroxide buffered with 0.1 M phosphate, and embed-
ded in epoxy resin. Sections were cut using an ultramicro-
tome, stained with uranyl acetate and lead citrate, and exam-
ined under an EM (Jeol, Tokyo, Japan) (16). The areas of
well-oriented, perpendicular, non-tangential epithelium and
underlying RBM were photographed. The thickness of RBM
was measured on photomicrographs.
Statistical analysis
Age, atopic index, FEV1, FVC, RBM, and subepithelial
layer thickness results are expressed as means±SD. PC20
values are expressed as geometric means±SD. The Kruskal-
Wallis and Mann-Whitney U tests were used for the analy-
sis, and results with p values of <0.05 were considered sig-
nificant. Data were analyzed using SPSS v12.0 (SPSS Inc.,
Chicago, IL, U.S.A.).
RESULTS
Subject characteristics 
Atopic subjects with asymptomatic AHR were aged from
24 to 29 yr (mean, 25.6±2.1), non-atopic subjects with
asymptomatic AHR 23-28 yr (mean, 25.4±2.5), atopic con-
trol groups 21-31 yr (mean, 27.0±4.8), non-atopic control
groups 23-32 yr (mean, 26.8±3.4), and mild atopic asth-
matics 21 or 22 yr. No statistical differences in age were found
among these 5 groups (p>0.05, Table 1). Geometric means
of PC20 were 2.58±0.53 in atopic subjects with asymptomat-
ic AHR, 2.41±0.64 in nonatopic subjects with asympto-
matic AHR, and 2.64±0.17 in mild atopic asthma pati-
ents, which were not statistically different (p>0.05, Table 1).
Mean atopic indexes were 1.72±0.76 in atopic subjects with
asymptomatic AHR, 1.94±0.54 in mild atopic asthma
patients, and 1.83±1.17 in atopic controls (p>0.05, Table
1). In addition, no significant difference was observed among
5 groups with respect to basal FEV1 and FVC (p>0.05,
Table 1).
Assessment of RBM thickness 
On EM, mean RBM thicknesses were 4.3±1.7  m in the
mild atopic asthma group, 3.4±1.8  m in the atopic
asymptomatic AHR group, 2.5±1.5  m in the non-atopic
asymptomatic AHR group, 2.6±1.1  m in the atopic con-
trols, and 2.3±1.2  m in the non-atopic controls (p=0.002,
Fig. 1). Corresponding maximum RBM thicknesses were
5.5±1.6 m,  4.5±1.8 m,  3.5±1.3 m,  3.4±0.8 m,
and 3.1±0.9 m,  respectively  (p=0.002), and correspond-
ing minimum RBM thicknesses were 3.0±0.7 m,  2.3±
AHR+
Atopy+ Atopy-
Asthma p value
AHR-
Atopy+ Atopy-
Number 5 7 7 7 2
Sex
Male 2 4 4 4 2
Female 3 3 3 3
Age (yr) 25.4 (22.3-28.5) 25.5 (2.1-0.78) 26.8 (23.2-30.4) 27.0 (22.6-31.4) 21.5 (15.2-27.8) NS
Atopic index (N+) 1.72±0.76 1.83±1.17 1.94±0.54 NS
*PC20 (mg/mL) 2.58±0.53 2.41±0.64 2.64±0.17 NS
FEV1 (%) 90 (82-98) 88 (76-101) 92 (81-103) 97 (86-109) 82.5 NS
FVC (%) 79 (70-88) 78 (67-89) 85 (77-93) 87 (71-103) 82.2 NS
Table 1. Patient characteristics
Results were expressed as mean±SD for age, atopy index, FEV1, and FVC. *PC20 were expressed as geometric mean±SD. Atopic index was defined
as the number of inhalant allergen categories (0-5) to which a patient showed at least one positive response on skin prick test.
AHR, asymptomatic airway hyperreponsiveness; NS, not significant.Atopy and Subepithelial Fibrosis in Asymptomatic Airway Hyperresponsiveness 393
1.0 m,  1.6±0.8 m,  1.9±0.9 m,  and  1.4±0.7 m,
respectively (p=0.015). Mean RBM thicknesses were signifi-
cantly higher in the mild atopic asthma group and the atopic
asymptomatic AHR group than in the other three groups
(p=0.048, Fig. 1, 2), which is also in minimum RBM thick-
nesses (p=0.037). Maximum RBM thicknesses showed a ten-
dency to be higher in the atopic asymptomatic AHR group
than in those of the non-atopic asymptomatic AHR group
and of the control groups (p=0.06). No significant differences
were observed between the atopic asymptomatic AHR group
and mild atopic asthma group in terms of mean RBM thick-
nesses (p>0.05, Fig. 1), nor between the non-atopic asymp-
tomatic AHR group and the two control groups in terms of
mean RBM thicknesses (p>0.05, Fig. 1).
Assessment of subepithelial layer thickness
On light microscopy, mean subepithelial layer thickness-
es were 6.1±3.1  m in the mild atopic asthma group, 5.1
±2.6  m in the atopic asymptomatic AHR group, 3.9±
1.8  m in the non-atopic asymptomatic AHR group, 3.9
±1.9  m in the atopic control group, and 3.8±1.7 m  in
the non-atopic control group (p=0.018, Fig. 3), and corre-
Fig. 2. Bronchial histopathology (electron microscopy, ×3,750) in (A) atopic asymptomatic AHR, (B) non-atopic asymptomatic AHR, (C)
mild atopic asthma, and (D) atopic control. RBM thicknesses showed greater in (A) and (C) than in (B) and (D).
A B
C D
Fig. 1. Reticular basement membrane (RBM) thicknesses. 
A, atopic asymptomatic AHR (n=5); B, non-atopic asymptomatic
AHR (n=7); C, mild atopic asthma (n=2); D, atopic control (n=7);
and E, non-atopic control (n=7). Horizontal bars within the graph
indicate the mean values. The mean values of RBM thicknesses
in A and C were significantly higher than in B, D, and E (p=0.048).
No significant differences were observed between A and C or
between B, D, and E in terms of mean RBM thickness. 
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sponding maximum subepithelial layer thicknesses were 8.4
±2.7 m,  7.1±2.0 m,  5.4±1.0 m,  5.6±1.1 m,  and
5.0±1.5 m,  respectively  (p=0.002), and minimum subep-
ithelial layer thicknesses were 3.8±1.5 m,  3.1±0.9 m,
2.3±0.5 m, 2.5±0.6  m, and 2.2±0.5 m,  respectively
(p=0.001). The mean values of subepithelial layer thickness-
es in the atopic asymptomatic AHR group were higher
than in the non-atopic asymptomatic AHR group and in
the two control groups (p=0.04, Fig. 3, 4), which is also in
maximum, and minimum values of subepithelial layer
thicknesses (p=0.005, p=0.008, respectively). No significant
differences were observed between the atopic asymptomatic
AHR and the mild atopic asthma groups in terms of mean
subepithelial layer thicknesses (p>0.05, Fig. 3), nor between
the non-atopic asymptomatic AHR group and the two con-
trol groups in terms of subepithelial layer thicknesses
(p>0.05, Fig. 3). 
Asymptomatic AHR subjects: follow-up
At 3-yr follow-ups, one of the seven atopic subjects with
asymptomatic AHR (14.3%) had developed asthma symp-
toms, including exercise-induced wheezing and cough. None
Fig. 3. Subepithelial layer thicknesses. A, atopic asymptomatic
AHR (n=5); B, non-atopic asymptomatic AHR (n=7); C, mild atopic
asthma (n=2); D, atopic control (n=7); and E, non-atopic control
(n=7). Horizontal bars within the graph indicate the mean values.
The mean values of subepithelial layer thicknesses in A and C
were significantly higher than in B, D, and E (p=0.04). No signifi-
cant differences were observed between A and C or between B,
D, and E in terms of mean subepithelial layer thickness.
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Fig. 4. Bronchial histopathology (light microscopy, H&E staining, ×400) in (A) atopic asymptomatic AHR, (B) non-atopic asymptomatic
AHR, (C) mild atopic asthma, and (D) atopic control. Subepithelial layer thicknesses showed greater in (A) and (C) than in (B) and (D). 
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of the seven non-atopic subjects with asymptomatic AHR
developed asthma symptoms. 
DISCUSSION
In this study, RBM and subepithelial layer thickening was
observed only in subjects with atopy among asymptomatic
AHR subjects. This is in concordance with the findings of a
previous asthma study (8), who reported that differences bet-
ween atopic and nonatopic asthma subjects were found in
terms of the degree of immunopathologic response. In that
study, bronchial subepithelial tenascin and laminin layers
were significantly thicker in the atopic group than in the
nonatopic asthma group, and the amount of epithelial dam-
age in the atopic asthma group was significantly greater than
in control subjects or nonatopic asthmatics. Taken together,
these findings suggest atopy may affect basement membrane
thickness in asymptomatic AHR and in asthma.
A limited number of studies have examined bronchial
inflammation and remodeling using bronchoscopic biopsies
in asymptomatic AHR subjects. Laprise et al. found that
asymptomatic AHR is associated with airway inflammation
and remodeling, but did not subanalyze data with respect
to atopic status (4). In that study, degrees of bronchial epithe-
lial desquamation in asymptomatic AHR subjects were sim-
ilar to those of asthmatic subjects, and CD3+, CD8+, and
CD25+ T lymphocytes and eosinophils were elevated in
the bronchial tissues of asymptomatic AHR subjects com-
pared with in those of normal controls. However, they found
that focal rather than continuous bronchial subepithelial
fibrosis in asthmatics, and RBM thicknesses were not statis-
tically different from those of normal controls. In our pre-
sent study, we determined RBM maximum and minimum
thicknesses at three different sites per bronchial biopsies. In
terms of mean, minimum, and maximum values, RBM thick-
nesses were greater in asymptomatic AHR with atopy than
in asymptomatic AHR without atopy or in normal controls.
Moreover, these thicknesses were not focal but continuous,
and were as great as observed in the two mild atopic asth-
matic subjects.
Atopy and asymptomatic AHR may be independent risk
factors of airway inflammation and remodeling. It has been
suggested in familial studies of asthma and allergy that atopy
and AHR are inherited independently (17, 18). The present
study showed that RBM and subepithelial layer thicknesses
were not elevated in non-atopic subjects with asymptomatic
AHR or in atopic control subjects without asymptomatic
AHR. In fact, RBM and subepithelial layer thicknesses were
increased only in subjects with both atopy and asymptomatic
AHR, indicating that atopy and asymptomatic AHR might
additively or synergistically induce airway remodeling. 
Asymptomatic AHR subjects may develop respiratory
symptoms, and eventually asthma, more rapidly if they have
atopy. Laprise et al. showed that four of 28 asymptomatic
AHR subjects develop asthma symptoms after a 3-yr follow-
up, and all four were sensitized to indoor allergens (4). Sev-
eral reports have shown that the majority of subjects with
AHR who eventually develop respiratory symptoms have a
personal or family history of atopy (11, 17, 19-21). In the
present study, one of seven subjects with atopic asympto-
matic AHR developed asthma symptoms (exercise-induced
wheezing and cough) after a 3-yr follow-up, which suggests
that atopic asymptomatic AHR subjects may be more prone
to develop asthma symptoms than non-atopic asymptomat-
ic AHR subjects. 
It has been reported that the RBMs are significantly thick-
ened in rhinitis patients with or without asthma as compar-
ed with those of asymptomatic atopic or control subjects (6,
7). All of our study subjects denied rhinitis symptoms or
other atopic diseases such as eczema. Thus, we are able to
exclude the possibility that the RBM thickening observed
in asymptomatic AHR subjects was a feature of atopic rhinitis.
The present study is the first to report that RBM and subep-
ithelial layer are thickened in atopic and not in non-atopic
subjects with asymptomatic AHR, and that this degree of
thickening is comparable to that found in atopic asthma.
This finding suggests that immunopathologic mechanisms
differ in atopic and non-atopic asymptomatic AHR as in
atopic and non-atopic asthma (8). In conclusion, we suggest
that atopy may be an important determinant of subepithe-
lial fibrosis in subjects with asymptomatic AHR.
REFERENCES
1. Boulet LP. Asymptomatic airway hyperresponsiveness: a curiosity
or an opportunity to prevent asthma? Am J Respir Crit Care Med
2003; 167: 371-8.
2. Jansen DF, Timens W, Kraan J, Rijcken B, Postma DS. (A)symp-
tomatic bronchial hyper-responsiveness and asthma. Respir Med
1997; 91: 121-34.
3. Kim YK, Kim SH, Tak YJ, Jee YK, Lee BJ, Kim SH, Park HW,
Jung JW, Bahn JW, Chang YS, Choi DC, Chang SI, Min KU, Kim
YY, Cho SH. High prevalence of current asthma and active smok-
ing effect among the elderly. Clin Exp Allergy 2002; 32: 1706-12.
4. Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic air-
way hyperresponsiveness: relationships with airway inflammation
and remodelling. Eur Respir J 1999; 14: 63-73.
5. Boulet LP, Prince P, Turcotte H, Lemiere C, Olivenstein R, Laprise
C, Larivee P, Begin P, Laviolette M. Clinical features and airway
inflammation in mild asthma versus asymptomatic airway hyperre-
sponsiveness. Respir Med 2006; 100: 292-9.
6. Braunstahl GJ, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden
HC, Prins JB. Mucosal and systemic inflammatory changes in aller-
gic rhinitis and asthma: a comparison between upper and lower air-
ways. Clin Exp Allergy 2003; 33: 579-87.
7. Milanese M, Crimi E, Scordamaglia A, Riccio A, Pellegrino R, Canon-396 S.-W. Sohn, Y.-S. Chang, H.-S. Lee, et al.
ica GW, Brusasco V. On the functional consequences of bronchial
basement membrane thickening. J Appl Physiol 2001; 91: 1035-40.
8. Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E,
Roomans GM, Boman G, Seveus L, Venge P. Inflammation and
structural changes in the airways of patients with atopic and nonatopic
asthma. Am J Respir Crit Care Med 2000; 162: 2295-301.
9. Laprise C, Boulet LP. Asymptomatic airway hyperresponsiveness: a
three-year follow-up. Am J Respir Crit Care Med 1997; 156: 403-9.
10. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM,
Herbison GP, Sears MR. Outcome in adulthood of asymptomatic
airway hyperresponsiveness in childhood: a longitudinal popula-
tion study. Pediatr Pulmonol 2002; 34: 164-71.
11. Kerkhof M, Schouten JP, De Monchy JG. The association of sensi-
tization to inhalant allergens with allergy symptoms: the influence
of bronchial hyperresponsiveness and blood eosinophil count. Clin
Exp Allergy 2000; 30: 1387-94.
12. American Thoracic Society. Standards for the diagnosis and care of
patients with chronic obstructive pulmonary disease (COPD) and
asthma. Am Rev Respir Dis 1987; 136: 225-44.
13. Kim YK, Chang YS, Lee MH, Hong SC, Bae JM, Jee YK, Chun
BR, Cho SH, Min KU, Kim YY. Role of environmental exposure to
spider mites in the sensitization and the clinical manifestation of asth-
ma and rhinitis in children and adolescents living in rural and urban
areas. Clin Exp Allergy 2002; 32: 1305-9.
14. Kim YK, Park HS, Kim HY, Jee YK, Son JW, Bae JM, Lee MH,
Cho SH, Min KU, Kim YY. Citrus red mite (Panonychus citri) may
be an important allergen in the development of asthma among expos-
ed children. Clin Exp Allergy 2001; 31: 582-9.
15. American Thoracic Society. Medical section of the American lung
association. Guidelines for fiberoptic bronchoscopy in adults. Am
Rev Respir Dis 1987; 136: 1066.
16. Park SH, Kim MK, Kim H, Song BJ, Chi JG. Ultrastructural stud-
ies of gastrointestinal stromal tumors. J Korean Med Sci 2004; 19:
234-44.
17. Gray L, Peat JK, Belousova E, Xuan W, Woolcock AJ. Family pat-
terns of asthma, atopy and airway hyperresponsiveness: an epidemi-
ological study. Clin Exp Allergy 2000; 30: 393-9.
18. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Air-
way remodeling in asthma: new insights. J Allergy Clin Immunol
2003; 111: 215-25.
19. Rasmussen F, Lambrechtsen J, Siersted HC, Hansen HS, Hansen NC.
Asymptomatic bronchial hyperresponsiveness to exercise in child-
hood and the development of asthma related symptoms in young
adulthood: the odense schoolchild study. Thorax 1999; 54: 587-9.
20. Xuan W, Peat JK, Toelle BG, Marks GB, Berry G, Woolcock AJ.
Lung function growth and its relation to airway hyperresponsiveness
and recent wheeze. Results from a longitudinal population study. Am
J Respir Crit Care Med 2000; 161: 1820-4.
21. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-
up study of ventilatory function in adults with asthma. N Engl J Med
1998; 339: 1194-200.